MPX-004
MPX-004 je antagonist NMDA receptora.[3]
![5-[[(3-hloro-4-fluorofenil)sulfonilamino]metil]-N-[(2-metil-1,3-tiazol-5-il)metil]pirazin-2-karboksamid](http://upload.wikimedia.org/wikipedia/commons/c/cb/MPX-004.png)
| |
| Nazivi | |
|---|---|
| IUPAC naziv
5-[[(3-hloro-4-fluorofenil)sulfonilamino]metil]-N-[(2-metil-1,3-tiazol-5-il)metil]pirazin-2-karboksamid
| |
Drugi nazivi
| |
| Identifikacija | |
3D model (Jmol)
|
|
| |
| Svojstva | |
| C17H15ClFN5O3S2 | |
| Molarna masa | 455,91 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Reference
уреди- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.